Literature DB >> 18392326

Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism.

Richard H White1, Hong Zhou, Susan Murin.   

Abstract

The incidence of death due to recurrent pulmonary embolism (PE) after a first-time idiopathic PE is not well defined. We conducted a retrospective study of patients age 18 to 56 years who had idiopathic PE between 1994-2001. The incidence and cause of death within five years was determined using linked discharge records and a master death registry. A total of 3,456 patients had a first-time idiopathic PE. The rate of recurrent VTE 0-6 months after the index event was 13.1%/year, and 2.9%/year 6-60 months after the event. During the mean follow-up of 3.2 years 118 (3.4%, 95% confidence interval [CI] = 2.8-4.1%) patients died. Fifty-two (44%) deaths occurred <29 days after the index PE (case-fatality rate = 1.5%, 95%CI = 1.1-2.0%). Among the 66 cases (1.9%) that died after 28 days, 18 (0.52%) were due to recurrent PE or its sequelae: eight had recurrent PE alone, five had recurrent PE and a serious co-morbid illness, and five had thromboembolic pulmonary hypertension with or without acute PE. The person-time rate of death (deaths per 100 patient-years) attributed to any recurrent thromboembolism 6-60 months after the event was 0.16% (95%CI = 0.1-0.26%). Ten of the 18 (56%) late thromboembolic deaths reflected a first-time recurrent PE. The 28-day case-fatality rate for recurrent VTE was 2.8% (95%CI = 1.5-4.9%). In this cohort of younger patients with idiopathic PE, the rate of death due to recurrent VTE, particularly to first-time recurrent PE, was low. Among the patients who died of thromboembolism >28 days after the index PE, 28% had developed pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392326     DOI: 10.1160/TH07-09-0557

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Anticoagulant treatment for subsegmental pulmonary embolism.

Authors:  Hugo Hb Yoo; Vania Santos Nunes-Nogueira; Paulo J Fortes Villas Boas
Journal:  Cochrane Database Syst Rev       Date:  2020-02-07

2.  Optimal duration of anticoagulation after venous thromboembolism.

Authors:  Samuel Z Goldhaber; Gregory Piazza
Journal:  Circulation       Date:  2011-02-15       Impact factor: 29.690

3.  Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France.

Authors:  Aurore Tricotel; Fanny Raguideau; Cédric Collin; Mahmoud Zureik
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 4.  Epidemiology of recurrent venous thrombosis.

Authors:  D D Ribeiro; W M Lijfering; S M Barreto; F R Rosendaal; S M Rezende
Journal:  Braz J Med Biol Res       Date:  2011-12-23       Impact factor: 2.590

5.  Unprovoked pulmonary embolism in older adults: incidence and prognosis.

Authors:  Mor Aharoni; Nir Horesh; Ori Rogowski; Anjelika Kremer; Haim Mayan; Dan Justo
Journal:  Arch Med Sci       Date:  2021-02-26       Impact factor: 3.318

Review 6.  Recurrent venous thromboembolism: what is the risk and how to prevent it.

Authors:  Gualtiero Palareti
Journal:  Scientifica (Cairo)       Date:  2012-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.